SEC 13F Intelligence

Amitell Capital Pte Ltd / RCKT

Amitell Capital Pte Ltd’s Rocket Pharmaceuticals Inc Position

Does Amitell Capital Pte Ltd own Rocket Pharmaceuticals Inc (RCKT)? Yes — 178.8K shares worth $639,993 (+1.03% of its 13F portfolio) as of Q1 2026.

Position Value
$639,993
Q1 2026
Shares
178.8K
% of Portfolio
+1.03%
Quarters Held
6
currently held

Position History RCKT

Reported value by quarter
Q1 ’22: $2MQ1 ’22Q2 ’22: $1MQ2 ’22Q2 ’25: $556,150Q2 ’25Q3 ’25: $582,787Q3 ’25Q4 ’25: $627,479Q4 ’25Q1 ’26: $639,993Q1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026178.8K$639,993+1.03%
Q4 2025178.8K$627,479+0.70%
Q3 2025178.8K$582,787+0.36%
Q2 2025227.0K$556,150+0.29%
Q2 202297.3K$1M+3.05%
Q1 202297.3K$2M+0.90%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Amitell Capital Pte Ltd’s full portfolio or all institutional holders of RCKT.